Evidence map›Paper›PMID 38725879›Full record

ArticleBone reports2024

Amyloid-β neuropathology induces bone loss in male mice by suppressing bone formation and enhancing bone resorption.

Younghun Jung, Birol Ay, Sajin M Cyr, Christina M Tognoni, Kaitlin Klovdahl, Julia Matthias, Qiuxia Cui, Daniel J Brooks, Mary L Bouxsein, Isabel Carreras and 2 more

Abstract read
In one paragraph

Article in Bone reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Younghun JungThe Endocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
Birol AyThe Endocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
Sajin M CyrThe Endocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
Christina M TognoniDepartment of Veterans Affairs, VA Boston Healthcare System, Boston, MA 02130, USA.
Kaitlin KlovdahlThe Endocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
Julia MatthiasThe Endocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
Qiuxia CuiThe Endocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
Daniel J BrooksThe Endocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
Mary L BouxseinThe Endocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
Isabel CarrerasDepartment of Veterans Affairs, VA Boston Healthcare System, Boston, MA 02130, USA.
Alpaslan DedeogluDepartment of Veterans Affairs, VA Boston Healthcare System, Boston, MA 02130, USA.
Murat BastepeThe Endocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.

Funding

Translational Imaging and Phenotyping CoreP30AR075042 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · PI MARY L BOUXSEIN, PAOLA DIVIETI PAJEVIC · 2019 to 2026
$7.4M
Sphingosine-1-phosphate induced modulation of inflammation in aging and Alzheimer's diseaseRF1AG056032 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI DEDEOGLU, ALPASLAN, JENKINS, BRUCE G · 2017 to 2017
$2.8M
Skeletal FGF23 production mediated by GPCR/Gq/PKC signalingR01DK121776 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI BASTEPE, MURAT · 2020 to 2024
$2.4M
NIAMS NIH HHS P30 AR075042NIA NIH HHS RF1 AG056032NIDDK NIH HHS R01 DK121776
6 · The paper itself

Abstract

Alzheimer's disease (AD) and osteoporosis often coexist in the elderly. Although observational studies suggest an association between these two diseases, the pathophysiologic link between AD and skeletal health has been poorly defined. We examined the skeletal phenotype of 5xFAD mice, an AD model with accelerated neuron-specific amyloid-β accumulation causing full-blown AD phenotype by the age of 8 months. Micro-computed tomography indicated significantly lower trabecular and cortical bone parameters in 8-month-old male, but not female, 5xFAD mice than sex-matched wild-type littermates. Dynamic histomorphometry revealed reduced bone formation and increased bone resorption, and quantitative RT-PCR showed elevated skeletal RANKL gene expression in 5xFAD males. These mice also had diminished body fat percentage with unaltered lean mass, as determined by dual-energy X-ray absorptiometry (DXA), and elevated

Indexed as

5xFAD mouse modelAlzheimer's diseaseBone metabolismOsteoporosis

Identifiers

PMID38725879
PMCPMC11078651

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.